RACHEL MILLER: Open Payments
NPI 1013956291 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,299 in 193 payments from 21 companies in 2025. Trend: 2023 $4,524 · 2024 $4,133 · 2025 $3,299
Food & beverage: $3,129Education: $170
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $696 |
| Janssen Biotech, Inc. | 35 | $546 |
| UCB, Inc. | 11 | $324 |
| GENZYME CORPORATION | 12 | $232 |
| Novartis Pharmaceuticals Corporation | 13 | $218 |
| Lilly USA, LLC | 8 | $209 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $180 |
| Galderma Laboratories, L.P. | 20 | $166 |
| Regeneron Healthcare Solutions, Inc. | 10 | $141 |
| Incyte Corporation | 6 | $108 |
Products named: TREMFYA, RINVOQ, DUPIXENT, Bimzelx, SKYRIZI, TALTZ, NEMLUVIO, OPZELURA.
Industry payments across TX — which companies pay providers there.
